-
The 'weight loss elixir' can reduce the risk of cardiovascular disease. Novo Nordisk: Not just the result of weight loss
On Saturday (November 11th) local time, Danish pharmaceutical giant Novo Nordisk stated that its weight loss drug Wegovy can reduce the risk of cardiovascular disease, and Wegovy's protective effect ... -
Another step ahead of Lilly! Novo Nordisk Wegovy approved by the US FDA for use in cardiovascular disease
On Friday, March 8th local time, the US Food and Drug Administration (FDA) approved the celebrity weight loss drug Wegovy to reduce the risk of stroke and heart attack in overweight or obese adults. ...